BIOCLINICA INC | 2012 | FY | 2


(in thousands)

December 31,

 

2012

 

2011

Billed trade accounts receivable

21,127 

 

14,070 

Unbilled trade accounts receivable

1,374 

 

2,283 

Other

119 

 

-

Total net receivables

22,620 

 

16,353 

 

Allowance Rollforward:

 

Balance at December 31, 2010

$
15 

Additions

22 

Write offs (net of recoveries)

(15)

Balance at December 31, 2011

$
22 

Additions

12 

Write offs (net of recoveries)

(22)

Balance at December 31, 2012

$
12 

 


us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended December 31,

(in thousands, except per share data)

 

 

 

2012

 

 

2011

 

 

2010

Net income  – basic and diluted

 

 

$

3,727 

 

$

2,798 

 

$

2,753 

 

 

 

 

 

 

 

 

 

 

 

Denominator – basic:

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares

 

 

 

15,626 

 

 

15,652 

 

 

15,035 

Basic income per common share

 

 

$

0.24 

 

$

0.18 

 

$

0.18 

 

 

 

 

 

 

 

 

 

 

 

Denominator – diluted:

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares

 

 

 

15,626 

 

 

15,652 

 

 

15,035 

Incremental shares from assumed conversions

 

 

 

 

 

 

 

 

 

 

of stock based compensation plans

 

 

 

860 

 

 

780 

 

 

839 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of dilutive common equity shares

 

 

 

16,486 

 

 

16,432 

 

 

15,874 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted income per common share

 

 

$

0.23 

 

$

0.17 

 

$

0.17 

 


us-gaap:ScheduleOfCalculationOfNumeratorAndDenominatorInEarningsPerShareTableTextBlock